QT Vascular Announces Positive Outcome In Spectranetics/Angioscore Patent Trial

30 9 月 2015

News

QT VASCULAR ANNOUNCES POSITIVE OUTCOME IN SPECTRANETICS/ANGIOSCORE PATENT TRIAL

Related Posts

Could Singapore become the next global biotech hub?

EdgeQ Closes $75M Series-B Investment and Ramps to Customers’ Demand for Its Award-Winning 5G+AI Base Station-on-a-Chip for 5G Networks

Proxtera announces successful first close, of Series Seed round of funding with Ant Group, CerraCap Ventures, and EDBI

What to watch in the biomedical space over the next five years

E-Newsletters

The Upside – EDBI E-Newsletter 2022 Q4

Reports

Our Inaugural Sustainability Report 2021/2022

Join our community!

Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.

Investing in high-growth technologies that shape the future economic pillars of Singapore since 1991.

About EDBI

Team

Portfolio

News and Insights

Careers

Contact Us

© 2023 EDBI. All rights reserved.